Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Degenhardt · SciRah

Researcher profile · Semantic Scholar

T. Degenhardt

Share profile

T. Degenhardt — researcher profile on SciRah

h-index: 11
Works: 56
Citations: 737

Most-cited papers

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
O. Gluz, U. Nitz, M. Christgen, R. Kates +17 more
2016Journal of Clinical Oncology286 citations
Semantic Scholar
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
Tanja K. Eggersmann, T. Degenhardt, O. Gluz, R. Wuerstlein +1 more
2019BioDrugs98 citations
Semantic Scholar
Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery
A. Pfob, C. Sidey-Gibbons, G. Rauch, Bettina C. Thomas +23 more
2022Journal of Clinical Oncology62 citations
Semantic Scholar
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
N. Harbeck, P. Fasching, R. Würstlein, T. Degenhardt +13 more
2023Annals of Oncology38 citations Open access
Semantic Scholar
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.
G. Bottoni, A. Piccardo, F. Fiz, G. Siri +16 more
2021European Journal of Radiology34 citations Open access
Semantic Scholar
Surgical management of ipsilateral breast tumor recurrence.
T. Kolben, Theresa M. Schwarz, C. Goess, C. Blume +6 more
2015International Journal of Surgery25 citations Open access
Semantic Scholar
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective
M. Forster, R. Wuerstlein, A. Koenig, N. Amann +8 more
2021Breast23 citations Open access
Semantic Scholar
The “Sell in May” effect: A review and new empirical evidence
T. Degenhardt, B. Auer
201817 citations
Semantic Scholar
S4-3: Prospective Comparison of Risk Assessment Tools in Early Breast Cancer (Recurrence Score, uPA/PAI-1, Central Grade, and Luminal Subtypes): Final Correlation Analysis from the Phase III WSG-Plan B Trial.
O. Gluz, H. Kreipe, T. Degenhardt, R. Kates +10 more
201114 citations
Semantic Scholar
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.
N. Harbeck, R. Kates, T. Schinköthe, J. Schumacher +13 more
2023Cancer Treatment Reviews12 citations
Semantic Scholar
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
T. Kolben, D. Augustin, R. Armbrust, T. Kolben +7 more
2015Breast Cancer Research and Treatment11 citations
Semantic Scholar
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept
A. Pfob, Lie Cai, A. Schneeweiss, G. Rauch +26 more
2023Annals of Surgical Oncology10 citations Open access
Semantic Scholar
114PMolecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra-patient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program
A. Gennari, E. Brain, O. Nanni, E. M. Couselo +16 more
201710 citations Open access
Semantic Scholar
First Evidence for a Role of Siglec-8 in Breast Cancer
Anna Trebo, N. Ditsch, T. Degenhardt, C. Kuhn +9 more
2021International Journal of Molecular Sciences8 citations Open access
Semantic Scholar
Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.
S. Kahlert, T. Kolben, E. Schmoeckel, B. Czogalla +6 more
2018European Journal of Surgical Oncology8 citations
Semantic Scholar
Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer
T. Kolben, T. Kolben, I. Himsl, T. Degenhardt +5 more
2016Breast Care8 citations Open access
Semantic Scholar
CANKADO PRO-React eHealth support in patients with HR+ HER2- metastatic breast cancer receiving palbociclib and endocrine therapy and the affect on time to deterioration of quality of life: Primary outcome analysis of the multicenter randomized PreCycle trial.
N. Harbeck, P. Fasching, R. Wuerstlein, T. Degenhardt +13 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer
H. Ni, J. Kumbrink, D. Mayr, A. Seiler +7 more
2021Journal of Personalized Medicine7 citations Open access
Semantic Scholar
Documentation patterns and impact on observed side effects of the CANKADO ehealth application: An exploratory analysis of the PreCycle trial.
T. Degenhardt, N. Harbeck, P. Fasching, R. Wuerstlein +6 more
20207 citations
Semantic Scholar
Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients
M. Burgmann, K. Hermelink, A. Farr, Friederike van Meegen +8 more
2018Breast Care7 citations Open access
Semantic Scholar
ADAPTlate: A randomized, controlled, open-label, phase III trial on adjuvant dynamic marker—Adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high-risk, HR+/HER2- early breast canc
O. Gluz, I. Scheffen, T. Degenhardt, N. Marschner +13 more
20216 citations
Semantic Scholar
Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology
T. Kolben, B. Haberland, T. Degenhardt, M. Burgmann +7 more
2018Archives of Gynecology and Obstetrics6 citations
Semantic Scholar
IL-23, IFN-α, and IFN-β in the vaginal fluid of patients suffering from vulvovaginal candidosis.
T. Kolben, K. Pieper, C. Goess, T. Degenhardt +4 more
2017Clinical and experimental obstetrics & gynecology6 citations Open access
Semantic Scholar
Prospective comparison of recurrence score, uPA/PAI-1, central grade and molecular classification in early breast cancer: Interim results from the WSG-Plan B trial.
T. Degenhardt, O. Gluz, H. Kreipe, R. Kates +6 more
2011Journal of Clinical Oncology4 citations
Semantic Scholar
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?
T. Kolben, Maximilian Bardenhewer, T. Kolben, Laura Rickerl +4 more
2019Breast Care3 citations Open access
Semantic Scholar
Individuelle Tumortherapie beim Mammakarzinom – Möglichkeiten der Vermeidung von Über- und Untertherapie unter besonderer Berücksichtigung zielgerichteter Therapien
T. Degenhardt, N. Harbeck, R. Würstlein
2015Deutsche Zeitschrift für Onkologie3 citations
Semantic Scholar
Prospective comparison of recurrence score and independent central pathology assessment of prognostic tools in early breast cancer (BC): Focus on HER2, ER, PR, Ki-67 results from the phase III WSG-Plan B trial.
O. Gluz, H. Kreipe, M. Christgen, T. Degenhardt +16 more
20123 citations
Semantic Scholar
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
M. Monti, T. Degenhardt, E. Brain, R. Wuerstlein +17 more
2022Frontiers in Medicine2 citations Open access
Semantic Scholar
The safety of palbociclib for the treatment of advanced breast cancer
T. Degenhardt, R. Wuerstlein, Tanja K. Eggersmann, N. Harbeck
2018Expert Opinion on Drug Safety2 citations
Semantic Scholar
11O Prospective Comparison of Risk Assessment Tools in Early Breast Cancer: Correlation Analysis from the Phase III Wsg-Plan B Trial
O. Gluz, H. Kreipe, T. Degenhardt, M. Salem +6 more
20122 citations Open access
Semantic Scholar
Abstract P2-09-05: Risk Group Selection in Primary Breast Cancer According to ASCO Recommended Biomarkers Onkotype DX and uPA/PAI-1: First Experience from Prospective Multicenter WSG Plan B Trial
T. Degenhardt, O. Gluz, C. Thomssen, M. Vetter +11 more
20102 citations
Semantic Scholar
Empowering of Oncology Patients and Informal Caregivers: Analysis of an Interdisciplinary Seminar Model for Breast Cancer and Gyneco-Oncological Patients
Hannah Hollaender, P. Ortner, A. Koenig, Nicole Erickson +6 more
2024Oncology Research and Treatment1 citations
Semantic Scholar
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy
Moritz Dimpfl, D. Mayr, E. Schmoeckel, T. Degenhardt +3 more
2022Breast Care1 citations Open access
Semantic Scholar
Abstract OT-01-02: Adaptlate -a randomized, controlled, open-label, phase-iii trial on adjuvant dynamic marker - adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, hr+/he
O. Gluz, T. Degenhardt, N. Marschner, M. Christgen +8 more
20211 citations
Semantic Scholar
PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy
T. Degenhardt, P. Fasching, D. Lüftner, V. Müller +14 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Palbociclib in daily clinical use: Real world experience of the breast center at the University Hospital Munich.
A. Hester, A. Koenig, F. Dobler, T. Degenhardt +6 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
S22ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution.
M. Monti, Davide Corradengo, O. Nanni, A. Piccardo +16 more
20161 citations Open access
Semantic Scholar
Promoting exercise in oncological aftercare
Hannah Pfeifle, T. Degenhardt, Petra Thaller
2026Physical Activity, Exercise and Cancer0 citations Open access
Semantic Scholar
Comparison of Prosigna® Assay and Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Results in Early-Stage Breast Cancer Patients
Laura Rickerl, Harald Bartsch, N. Harbeck, D. Hofmann +4 more
2025Breast Care0 citations Open access
Semantic Scholar
195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy
N. Harbeck, R. Kates, T. Schinköthe, J. Schumacher +13 more
2023ESMO Open0 citations Open access
Semantic Scholar
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment—A New Concept
A. Pfob, Lie Cai, A. Schneeweiss, G. Rauch +26 more
2023Annals of Surgical Oncology0 citations
Semantic Scholar
Abstract PD7-02: Intelligent vacuum-assisted breast biopsy to identify breast cancer patients with pathologic complete response after neoadjuvant systemic treatment for omission of breast and axillary surgery
A. Pfob, C. Sidey-Gibbons, G. Rauch, Bettina C. Thomas +22 more
2022Cancer Research0 citations
Semantic Scholar
Abstract PS13-32: Hormone- and HER2 receptor change in non-pCR breast cancer specimens after neoadjuvant treatment
Moritz Dimpfl, T. Degenhardt, D. Mayr, E. Schmoeckel +2 more
20210 citations
Semantic Scholar
1592P Willingness to vaccinate and side effects of COVID-19 vaccination in patients with breast cancer and gynecological malignancies
M. Forster, R. Würstlein, A. König, S. Beyer +6 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
55P Molecular risk factors for distant metastases in premenopausal patients with HR+/HER2- EBC
H. Ni, J. Kumbrink, D. Mayr, A. Seiler +6 more
20210 citations Open access
Semantic Scholar
Abstract OT3-14-02: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy - Precycle
T. Degenhardt, P. Fasching, D. Lüftner, V. Mueller +14 more
20200 citations
Semantic Scholar
Abstract OT3-14-01: GERA: A health economic trial to analyze the impact of ehealth in breast cancer care
Tanja K. Eggersmann, C. Riese, C. Wenzel, T. Schinkoethe +4 more
20200 citations
Semantic Scholar
Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system
Marcus Schmidt, T. Degenhardt, P. Fasching, D. Lüftner +15 more
20200 citations
Semantic Scholar
Gene expression profiles in premenopausal women with HR+ HER2- early breast cancer
H. Ni, A.-G. Kurt, Jörg Kumbrink, A. Seiler +6 more
2020Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Late Presentation at Primary Diagnosis of Breast Cancer: Patients’ Personality Characteristics and Attitudes
T. Kolben, S. Beyer, Sanaz Ghasemi, K. Hermelink +9 more
2020Breast Care0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Harbeck×32
Invite
N. Harbeck — researcher profile on SciRah
R. Wuerstlein×26
Invite
R. Wuerstlein — researcher profile on SciRah
R. Kates×17
Invite
R. Kates — researcher profile on SciRah
O. Gluz×13
Invite
O. Gluz — researcher profile on SciRah

×11

Invite

T. Kolben — researcher profile on SciRah

Invite

S. Mahner — researcher profile on SciRah

R. Würstlein×9

Invite

R. Würstlein — researcher profile on SciRah

Invite

U. Nitz — researcher profile on SciRah

Invite

M. Reinisch — researcher profile on SciRah

Invite

D. Lüftner — researcher profile on SciRah

J. Schumacher×8

Invite

J. Schumacher — researcher profile on SciRah

Invite

S. Kuemmel — researcher profile on SciRah